2026 NPPES data Ophthalmology Physician NPI 1669477956 M.D.
Verify on CMS →

ALMERINDO PORTFOLIO, M.D.

Ophthalmology Physician in GLEN ROCK, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
383
Medicare Part D claims · 53 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
67%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$15.12
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ALMERINDO PORTFOLIO, M.D. filed 383 Medicare Part D claims in 2023 as a Ophthalmology Physician in GLEN ROCK, New Jersey, prescribing 67% generic.

383
Part D claims, 2023
67%
generic prescribing
$15.12
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ALMERINDO PORTFOLIO, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

383 Top 43% higher than 57% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

ALMERINDO PORTFOLIO, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ALMERINDO PORTFOLIO, M.D.?

Quality data not reported

NPI registry status

Active

Issued 06/15/2005

NPI 1669477956

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

383 73% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

Specialty distribution in New Jersey

How Ophthalmology Physician compares to other specialties among New Jersey providers

New Jersey providers

Ophthalmology Physician share within New Jersey

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within New Jersey

Specialty board-certification context

Estimated specialty board-certified rate — Ophthalmology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ophthalmology Physician ABMS/AOA estimate

Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALMERINDO PORTFOLIO, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 85 HARRISTOWN RD, GLEN ROCK, NJ, 07452, with a listed phone of (201) 445-5161. NPI 1669477956 was issued on 06/15/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PORTFOLIO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 383 prescription claims written by this provider, covering 53 Medicare beneficiaries and totaling roughly $80K in drug spend, split 33% brand-name and 67% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

85 HARRISTOWN RD
GLEN ROCK, NJ 07452

Provider Details

NPI 1669477956
Specialty Ophthalmology Physician
Credentials M.D.
Gender Male
NPI Issued 06/15/2005

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ALMERINDO PORTFOLIO, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$15

Largest payer

Tarsus Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

ALMERINDO PORTFOLIO, M.D. — brand share 33.0%
Specialty average (est.)

33% brand-name claims vs 67% generic, on 383 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

383
Total Claims
$80K
Total Drug Cost
53
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
639
Total Day Supply
17,955
Brand vs Generic
33% brand / 67% generic
Brand Drug Cost
$71K
Generic Drug Cost
$9K

Patient Demographics

Average Patient Age
83.9 years
Avg HCC Risk Score
1.28
Gender Split
64% female / 36% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ALMERINDO PORTFOLIO, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
115
Timolol Maleate
30
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
27
Brimonidine Tartrate
18
Restasis
Cyclosporine
18
Rocklatan
Netarsudil Mesylat/Latanoprost
18
Loteprednol Etabonate
17
Travoprost
16
Valacyclovir
Valacyclovir Hcl
14
Combigan
Brimonidine Tartrate/Timolol
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How ALMERINDO PORTFOLIO, M.D. fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

ALMERINDO PORTFOLIO, M.D.'s 383 claims are below the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as PORTFOLIO.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALMERINDO PORTFOLIO, M.D.'s specialty?
ALMERINDO PORTFOLIO, M.D. specializes in Ophthalmology Physician and practices in GLEN ROCK, New Jersey. Credentials: M.D..
How much does ALMERINDO PORTFOLIO, M.D. prescribe under Medicare Part D?
In 2023, ALMERINDO PORTFOLIO, M.D. wrote 383 Medicare Part D claims totaling $80K in drug costs for 53 beneficiaries.
Where is ALMERINDO PORTFOLIO, M.D. located?
ALMERINDO PORTFOLIO, M.D. is located at 85 HARRISTOWN RD, GLEN ROCK, NJ, 07452. Phone: (201) 445-5161.
What is ALMERINDO PORTFOLIO, M.D.'s NPI number?
ALMERINDO PORTFOLIO, M.D.'s National Provider Identifier (NPI) is 1669477956, issued on 06/15/2005.
Does ALMERINDO PORTFOLIO, M.D. prescribe more brand-name or generic drugs?
ALMERINDO PORTFOLIO, M.D.'s prescribing is 33% brand-name and 67% generic drugs by claim count, with $71K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does ALMERINDO PORTFOLIO, M.D. prescribe most often?
Based on 2023 Medicare Part D data, ALMERINDO PORTFOLIO, M.D.'s most frequently prescribed drugs include Latanoprost, Timolol Maleate, Dorzolamide-Timolol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALMERINDO PORTFOLIO, M.D. accept Medicare?
ALMERINDO PORTFOLIO, M.D. appears in CMS Medicare data with 383 Part D claims and 53 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALMERINDO PORTFOLIO, M.D.'s credentials?
ALMERINDO PORTFOLIO, M.D.'s NPI is 1669477956 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology